US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

fentaNYL as citrate 2 mcg / mL

Reason Lack Of Assurance Of Sterility.

SCA Pharmaceuticals, LLC NDC 70004-0264-64 D-0063-2018
Class II · Moderate risk Terminated

SUCcinylcholine 20 mg per mL

Reason Lack Of Assurance Of Sterility.

SCA Pharmaceuticals, LLC NDC 70004-0910-29 D-0059-2018
Class II · Moderate risk Terminated

Levetiracetam Oral Solution

Reason Presence of foreign substance (screw)

Hetero Labs, Ltd. - Unit III NDC 31722-574-47 D-0099-2018
Class II · Moderate risk Terminated

Ropivacaine HCL

Reason Lack of Assurance of Sterility.

Banner Pharmacy Services, LLC D-0024-2018
Class II · Moderate risk Terminated

Midazolam HCL 100 mg

Reason Lack of Assurance of Sterility.

Banner Pharmacy Services, LLC D-0021-2018
Class II · Moderate risk Terminated

Hydromorphone HCl 10 mg

Reason Lack of Assurance of Sterility.

Banner Pharmacy Services, LLC D-0019-2018
Class II · Moderate risk Terminated

fentanyl citrate

Reason Lack of Assurance of Sterility.

Banner Pharmacy Services, LLC D-0018-2018
Class II · Moderate risk Terminated

fentaNYL citrate 1000 mcg

Reason Lack of Assurance of Sterility.

Banner Pharmacy Services, LLC D-0017-2018
Class II · Moderate risk Terminated

A1 Slim

Reason Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared sibutramine, phenolphthalein, and n-desmethyl sibutramine, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.

Kiriko, LLC. D-0058-2018
Class II · Moderate risk Terminated

Duloxetine Delayed-release Capsules USP

Reason Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.

AVKARE Inc. NDC 50268-283-15 D-0055-2018